Influenza A virus (IAV) non-structural protein 1 (NS1) has multiple functions, is essential for virus replication and may be a good target for IAV diagnosis. To generate broadly cross-reactive NS1-specific mAbs, mice were immunized with A/Hong Kong/1/1968 (H3N2) 6¾His-tagged NS1 and hybridomas were screened with glutathione S-transferase-conjugated NS1 of A/Puerto Rico/8/ 1934 (H1N1). mAbs were isotyped and numerous IgG-type clones were characterized further. Most clones specifically recognized NS1 from various H1N1 and H3N2 IAV types by both immunoblot and immunofluorescence microscopy in mouse M1, canine Madin-Darby canine kidney and human A549 cells. mAb epitopes were mapped by overlapping peptides and selective reactivity to the newly described viral NS3 protein. These mAbs detected NS1 in both the cytoplasm and nucleus by immunostaining, and some detected NS1 as early as 5 h postinfection, suggesting their potential diagnostic use for tracking productive IAV replication and characterizing NS1 structure and function. It was also demonstrated that the newly identified NS3 protein is localized in the cytoplasm to high levels.
INTRODUCTION
Influenza A virus (IAV) is a negative-sense ssRNA virus with a segmented genome (reviewed by Palese & Shaw, 2007; Wright et al., 2007) . IAV belongs to the family Orthomyxoviridae and is subtyped based on its surface glycoproteins haemagglutinin (HA) and neuraminidase (NA). IAV circulates in humans and causes seasonal influenza infection with mild to severe illness but can also be life-threatening for adults, infants and immunodeficient people (Tan et al., 2010) . IAV also undergoes substantial antigenic variation, due to the low fidelity of RNA transcription and the segmented nature of the viral genome (Lindstrom et al., 1998) . In addition, 17 HA and 10 NA types have been identified so far (Tong et al., 2012;  reviewed by Palese & Shaw, 2007) . Genetic mixing of various genes, including the HA and NA genes, has led to the emergence of new strains that contribute to pandemics. IAV contains eight segments of RNA encoding ten to 15 viral proteins (reviewed by Jagger et al., 2012; Palese & Shaw, 2007; Wright et al., 2007) .
The viral non-structural protein NS1 is encoded by viral RNA segment 8 and is essential for virus replication in normal cells (reviewed by Hale et al., 2008) . NS1 is a relatively small multifunctional protein of 202-237 aa (Dundon, 2012) . Based on phylogenetic analysis, IAV NS1 proteins can be divided into two major groups: allele A, which contains the NS1 proteins of human, swine, avian and equine IAVs, and allele B, which contains only NS1 proteins of avian influenza viruses (Ludwig et al., 1991; Treanor et al., 1989) . All human seasonal influenza viruses contain allele A NS1. Most IAV antigenic changes are driven by selective pressures on the surface antigens HA and NA, and there is no correlation between the surface subtypes and the antigenic properties of NS1 (Brown et al., 1983) . NS1 interacts with both RNA and numerous host proteins, including RIG-I (Guo et al., 2007; Mibayashi et al., 2007; Opitz et al., 2007) , TRIM25 (Gack et al., 2009) , CPSF30 (Kochs et al., 2007a; Nemeroff et al., 1998) , PABPNI (Chen et al., 1999) and NXF1/TAP (Satterly et al., 2007) . NS1 appears to modulate viral gene splicing (Fortes et al., 1994; Garaigorta & Ortín, 2007; Robb et al., 2011) and is also involved in restraining host immune responses by inhibiting the production of interferon and interferoninduced proteins, which play important roles in antiviral activities (Bergmann et al., 2000; Egorov et al., 1998; García-Sastre et al., 1998; Jia et al., 2010; Kochs et al., 2007b ; reviewed by Hale et al., 2008) . We recently identified and characterized a panel of adaptive mutations that enhance interferon antagonism of the A/Hong Kong/ 1/1968 (H3N2) NS1 protein , one of which resulted in the generation of an alternatively spliced variant protein product, NS3, that possesses an in-frame deletion of aa 126-168 . Subcellular distribution of NS1 protein in infected cells depends on the virus strain, cell type and procedure of fixation. Although synthesized in the cytoplasm, large amounts of this nonstructural viral protein are found in the cytoplasm and nucleus (Greenspan et al., 1988; Hale et al., 2008; Li et al., 1998; Newby et al., 2007) and in nuclear ND10 structures (Sato et al., 2003) . NS1 has recently been demonstrated by computational analyses to contain 21 functional and 15 structural 'sequence features' Squires et al., 2012) , and several key amino acid residues play important roles in determining viral and host protein intracellular distribution (see, for example, Ayllon et al., 2012) .
As NS1 is the only IAV non-structural protein identified in all strains and is expressed in abundance after infection (Krug & Etkind, 1973) , it may be a good target for detection and diagnosis of productive IAV infection. Previous studies have generated mAbs against highly pathogenic H5N1 NS1 that were useful for viral detection and titration purposes (Rai et al., 2010; Tan et al., 2010) . In addition, NS1-targeted mAbs have been generated previously against A/WSN/1933 (H1N1) to analyse the antigenic variation in NS1 of a wide range of influenza viruses of different origins (Brown et al., 1983) . However, the most prevalent currently circulating human IAVs are of the H1N1 and H3N2 subtypes, and, as indicated above, there are a disproportionately large number of sequence features in the small, critically important viral NS1 protein. Thus, we sought to generate additional broadly crossreactive, yet highly NS1-specific, mAbs that might be useful for characterizing this important viral protein from a wide range of viral subtypes and to define additional sequence features.
RESULTS AND DISCUSSION
Anti-NS1 mAb production and isotyping IAVs undergo considerable genetic and antigenic variation among their constituent proteins. Phylogenetic analyses of various IAV genes have indicated that some, such as polymerase protein genes, are relatively highly conserved, whereas the major surface antigenic determinant proteins, HA and NA, are more variable (Palese & Shaw, 2007; Wright et al., 2007) . Assessment of variation among six laboratory strains that we routinely work with demonstrated these relative patterns among the encoded proteins (Fig. 1) . We observed that there was 96-99 % sequence identity between the PA proteins of three of our H1N1 strains, PR8, B59 and NCal (see Table 1 for viral strain abbreviations), 97-99 % sequence identity between our H3N2 PA proteins in HK1, NY55 and B10, and 95-96 % sequence identity between any two H1N1 and H3N2 PA proteins (Fig. 1a) . Comparisons of the HA proteins of this panel of viruses showed 79-97 % sequence identity between any two H1N1 strains and 86-98 % identity between any two H3N2 strains but only 38-41 % sequence identity between any H1N1 and H3N2 HA proteins (Fig. 1a) .
Similar comparative analysis of the NS1 protein showed intermediate values. There was .90 % identity between any two H1N1 members and .92 % identity between any two H3N2 group members but~83-85 % identity when comparing any H1N1 NS1 protein with any H3N2 NS1 protein (Fig. 1a) . Among this small group of prototype virus strains, the NS1 proteins of PR8 and HK1 were the most divergent (data not shown). For this reason, we adopted the strategy of selecting for broadly cross-reactive, yet NS1-specific, antibodies by immunizing with NS1 derived from the HK1 strain and screening hybridomas with NS1 derived from the PR8 strain.
After immunizing female BALB/c mice with 66His-tagged HK1 protein, spleen cells were collected and fused with myeloma cells and several hundred potential monoclonal hybridomas were screened for binding to GST-PR8-NS1 by ELISA. An initial Western blot screen identified several dozen positive hybridomas, which were then cloned by sequential limiting dilution twice. We continued analysis of the 13 strongest-reacting clones. Immunoglobulin isotyping indicated that one clone was IgM and 12 clones were IgG. Subtyping of the IgG types indicated that five were IgG2b, four were IgG2a, two were IgG1 and one was IgG3. Among these 12 IgG mAbs, 10 were able to detect recombinant GST-NS1 by Western blotting. Nine of these mAbs were successfully purified by protein G affinity chromatography and used for subsequent studies (Table 2) .
Anti-NS1 antibodies are specific for NS1 from multiple virus strains Each of the IAV strains, except HK1, which was employed in later assays, were initially used to infect Madin-Darby The sequence region in HK1 denoted by a black line above the sequences (aa 125-167) is missing in a recently described NS3 protein identified in a mouse-adapted strain . The strains are identified in (Fig. 1c) . The small variation in apparent molecular masses probably reflects the sequence differences between these strains. A much fainter band was occasionally observed at a higher molecular mass of~42 kDa, which may represent modified forms or oligomers of NS1. When mAb 3F5 was subsequently used to immunoprecipitate proteins from PR8-infected MDCK cell lysates, a single 26 kDa protein (in addition to the IgG chains) was observed following SDS-PAGE, and mass spectrometry identified this protein as PR8 NS1 (data not shown).
As analysis of the first antibody indicated that it bound NS1 with little if any background, we then used a slot-blot apparatus to rapidly screen each of our nine antibodies against mock-infected lysates, as well as lysates infected with each of five IAV strains. All nine mAbs were affinity purified on protein G columns and used in all remaining experiments. MDCK cell lysates (25 mg) infected with each IAV strain were bound to a PVDF membrane and probed with identical concentrations (1 mg) of each purified mAb. Eight of the purified IgG mAbs (13D8, 5D6, 10C7, 8C7, 5F4, 4E10, 3F5 and 7D11) detected the denatured form of NS1 of all five test IAV strains, whilst the ninth mAb, 5B10, bound denatured NS1 of only PR8, NY55 and NCal (Fig.  1d ). The mAbs also demonstrated different affinities. 5D6 recognized the NS1 proteins of most strains to almost the same extent, consistent with few alterations within the amino acid sequence (Fig. 1b) , as determined by subsequent epitope mapping. Similarly, 10C7, although it clearly had a higher affinity as demonstrated by stronger reactivity, also reacted nearly equally with most tested clones, with reactivity to NCal NS1 being the exception. However, a number of mAb clones demonstrated strainspecific reactivity. For example, 4E10 reacted most strongly with PR8 NS1 and less strongly with NS1 derived from other tested clones, all of which have sequence variation in the region subsequently determined to contain the epitope.
We then performed immunofluorescent microscopy to test the capacity of the mAbs to bind to the native form of NS1 and to observe subcellular NS1 distribution. This assessment was initiated with mAb 3F5. This mAb reacted with DEpitopes were determined by Pepscan Therapeutics using linear overlapping peptide arrays as described elsewhere (Slootstra et al., 1996) . Values correspond to amino acid positions within NS1.
all tested IAV strains, although 3F5 appeared to react more strongly with B59-and NCal-infected MDCK cells and more weakly with B10-infected MDCK cells (Fig. 2) . NS1 was found in both the cytoplasm and nucleus at the 24 h time point used for this initial assay. Similar analyses of other IAV strains with other mAbs showed variability in their capacities to recognize NS1 proteins from different IAV strains (Fig. 3) . For example, 5F4 and 13D8 reacted with all tested strains, whereas 5D6, 8C7 and 10C7 reacted very weakly, if at all, with B10, and all five tested mAbs detected PR8 and B59. Thus, several of these new mAbs recognized both denatured and native forms of several NS1 proteins.
PR8 NS1 is detected as early as 5 h p.i. by Western blotting
Time-course studies of MDCK cell infections indicated that the earliest time point at which PR8 NS1 could be detected by Western blotting was 5 h p.i. (Fig. 4a) . Detection of PR8 NS1 by immunofluorescence microscopy was less sensitive, and NS1 generally was not detectable before 6-8 h p.i. (Fig.  4b ). In addition, inspection of these images indicated that the subcellular distribution of NS1 changed over time. NS1 was detectable initially in subnuclear structures where it remained for several hours. Cytoplasmic staining became more apparent after 12 h p.i., and subnuclear staining was also apparent at this time. Cytoplasmic staining became more even and diffuse with longer incubation times, and the subnuclear staining appeared to diminish or disappear (Fig. 4b) .
Epitope mapping of the new NS1 mAbs
We recently described a panel of adaptive mutations in human IAV that were selected through several serial passages in mice Selman et al., 2012) . These mouse-adapted variants of HK1 possessed several mutations in the NS1 protein, including a D125G amino acid substitution (GATAGGT). The D125G mutation also induced an alternatively spliced transcript that resulted in deletion of an internal motif in the NS1 protein corresponding to aa 125-167. We called this novel splice variant protein NS3 . We tested our NS1 mAbs for their reactivity to both wild-type HK1 NS1 protein and the NS1 D125G mutant and NS3 proteins, grown in human A549 cells (data not shown) and mouse M1 cells, to determine whether any of the mAbs recognized an epitope within the deleted region. Most mAbs that detected HK1 NS1 also reacted with the NS3 protein. However, three mAbs, (3F5, 5F4 and 13D8) reacted with the HK1 NS1 but not NS3 (Fig. 5a ), indicating these mAbs react with an epitope(s) located between aa 125 and 167. In addition, a fourth mAb (5B10) reacted with NS3 but only at low levels.
To define more precisely the epitopes recognized by each mAb, aliquots of each antibody were submitted to Pepscan Therapeutics for overlapping peptide library analysis. Each mAb reacted with a defined set of peptides and allowed mapping of the epitope of each mAb (Fig. 5b) . Five different epitopes were identified. Most mAbs, such as 3F5 and 5B10, reacted with a limited number of linear peptides and generated single well-defined peaks. The 3F5 mAb reacted strongly with peptides only between NS1 aa 160 and 169, and therefore its epitope could be assigned to the sequence SPLPSLPGH. Likewise, the 5B10 epitope could be assigned to the sequence 138 FDRLETLILL 147 , overlapping with the previously described nuclear export signal sequence feature Squires et al., 2012) (Table 2) . Similarly,
DAPFLDR
35 , located within the RNA-binding domain, was the epitope recognized by 7D11.
29 DAPFLDR 35 was highly conserved amongst the tested IAV strains (Fig. 1b) and therefore this mAb reacted well with the NS1 of numerous tested IAV strains (Fig. 1d) . Several mAbs appeared to react with several linear peptides located in different regions of the NS1 protein. For example, 8C7 reacted with several peptides near aa 160 and 210 (Fig. 5b) , possibly due to cross-reactivity to these similar epitope regions possessing SPLPSLPGH and PPLTPKQK, respectively. To determine more precisely the respective contributions of each of these regions, we performed competitive ELISA, by treating plate-bound GST-PR8-NS1 with an excess of each of the various mAbs and then testing the capacity of biotinylated mAb 8C7 to react. Biotinylated 8C7 bound efficiently to NS1 pretreated with no antibody, an irrelevant antibody that recognizes b 1 integrin or mAb 7D11, which recognizes a distant epitope (Fig. 5c ). Biotinylated 8C7 binding was reduced to background levels by 5F4 and by nonbiotinylated 8C7, by~80 % by 3F5 and by~30 % by 4E10. These results, combined with the capacity of 8C7 to recognize NS3 (Fig. 5a ), suggested that 8C7 does recognize both epitopes. All nine of the mAbs epitopes could be mapped on the primary NS1 amino acid sequence map (Table 2 ) and eight were placed within the deduced threedimensional NS1 atomic structure (Fig. 5d-f) . The two mAbs that recognized 211 RPPLT 215 (4E10 and 8C7) bound near the disordered carboxyl terminus, which lacks a defined structure.
Discrimination of NS1 from NS3 in infected cells
The previous Western blot screening analyses of mAb binding to HK NS1 and NS3 proteins demonstrated that 3F5, 5F4 and 13D8 bound the spliced-out intronic region of NS1 that is absent from the NS3 protein. Thus, these mAbs can be used specifically to detect NS1 in the presence of NS3. We performed confocal microscopy with a rabbit polyclonal antibody to detect both NS1 and NS3, and mAb 3F5 to detect only NS1 protein, in mouse M1 cells infected with HK1 wild-type virus that only expressed NS1 or with the NS1 M124I/D125G mutant expressing both NS1 and NS3 (Fig. 6 ). 3F5 staining of NS1 protein in HK1 wild-type NS1-and the M124I/D125G-infected M1 cells at 16 h p.i. was primarily nuclear, with a low level of cytoplasmic On: Mon, 07 Jan 2019 00:25:08 staining detected with the M124/D125G mutant associated with higher NS1 expression . Polyclonal antibody staining of parallel samples also showed nuclear staining of the HK1 wild-type-infected cells but uniform staining of M124/D125G-infected cells involving both nuclear and cytoplasmic regions (differentiated by DAPI staining of the nuclei). The comparative staining patterns could be interpreted to indicate that the full-length HK1 wild-type and M124I/D125G mutant NS1 proteins were restricted primarily to the nucleus, whereas the polyclonal antibody detected additional staining of NS3 in the cytoplasm. This interpretation was supported by cellular fractionation into cytoplasm and nuclear fractions with detection of NS1 and NS3 proteins using the polyclonal antibody (Fig. 6b) . This subcellular fractionation showed that cells infected with the NS1 wild-type and M124I/ D125G mutant had a similar and primarily nuclear distribution of full-length NS1 (when normalized to nuclear and cytoplasmic markers histone H3 and atubulin, respectively). This was especially true for the M124I/D125G mutant that also expressed high levels of NS3 in both the cytoplasm and nucleus. These data therefore demonstrated the utility of mAb 3F5 for detecting full-length NS1 relative to the NS3 splice product that lacks this epitope, and furthermore indicated that NS1 protein and its variants possessing the 3F5 epitope can be discriminated from NS1 protein variants and deletion mutants that lack this epitope.
The novel mAbs bind to highly conserved IAV epitopes
This novel panel of defined NS1-specific mAbs will be useful for detecting NS1 proteins for diagnosis or characterization of infections. A screen of the .1800 non-redundant human IAV NS1 protein sequences available in the NCBI Influenza Virus Resource database (Bao et al., 2008) as of early November 2012, showed that three of these five epitopes are highly conserved across the majority of NS1 sequences. For example, the peptide sequences DCFLWHVR and DCFLWHIR, present in all six of our tested IAV strains and recognized by mAbs 5D6 and 10C7, are found in .95 % of currently available human IAV NS1 sequences. Likewise, the DAPFLDR sequence, recognized by mAb 7D11, is also found in .95 % of available sequences, and the peptides SPLPSLPGH and SPLPSFPGH, observed in all six of our tested strains and recognized by mAbs 3F5, 5F4 and 13D8, are found in .97 % of currently available human IAV NS1 sequences. Given that the three-dimensional structure of NS1 has been determined for H5N1 NS1, and that NS1 has been shown to bind to several host proteins, our defined panel of mAbs could be used as ligand probes for binding variants and deletion mutants used to map regions of NS1 protein biological properties, such as was shown for the NS3 and NS1 proteins (Fig. 6) . Similarly, the mAbs could be used to inhibit host interaction for assessment of the effects of blocking host factor binding to various sites in NS1.
METHODS
Production of recombinant proteins. Proteins were generated essentially as described by Sambrook et al. (1989) . Native 66His-tagged HK1 (H3N2) NS1 protein was expressed from a pET-17b (EMD Millipore) prokaryotic expression plasmid encoding NS1 in Escherichia coli. A cloned cDNA copy of the HK1 NS1 gene (GenBank accession no. CY033005) was amplified by PCR using NS1 forward (59-ATTAGCTAGCATGCATCACCATCACCATCACATGGATTCT-AACACTGTG-39) and reverse (59-CATGGAATTCTCAATCAGCC-ATCTTATC-39) primers. The PCR product was inserted into the NheI and EcoRI sites of pET-17b. Soluble recombinant 66His-tagged Bornholdt & Prasad, 2008) . Some NS1 sequence features (as defined by Squires et al., 2012) are indicated in colour: yellow, the RNA-binding domain encompassing aa 1-73; red, critical nuclear localization signal 1 (NLS-1; aa 35, 38 and 41); grey, eIF4GI interaction site (aa 81-113); black, TRIM25 interaction site (aa 96 and 97); bright pink, CPSF30-binding site (aa 103, 105-110, 117, 119-126, 151, 153, 155-157, 180, 181, 183, 184 and 187-189) ; blue, protein kinase R-binding site (aa 123, 124, 126, 127) ; cyan, nuclear export signal (aa 137-147); green, nuclear export signal mask (aa 148-161). Epitope residues are shown as coloured semi-transparent spheres in (d) and (e) and as solid spheres in (f) to correspond to various NS1 sequence features recognized by the indicated mAbs: orange, overlaps the RNA-binding domain and NLS-1; lime green, partially overlaps the nuclear export signal mask. Aa 1-4, 75-79 and 198-230 are disordered and not shown. The images in (d) and (e) correspond to the same orientations as in Bornholdt & Prasad (2008) , with (e) rotated 906 to show the 'top' of (d). The image in (f) represents an~906 rotation around the vertical axis. The disordered aa 75-79 are indicated by dashed lines.
Influenza NS1 mAbs NS1 protein was expressed and purified by nickel affinity binding, as described previously (Ping et al., 2011) .
A cloned cDNA copy of PR8 (H1N1) (GenBank accession no. EF190978) was amplified by PCR using the NS1 forward (59-ATCCCCGGAATTCCCATGGATCCAAACAC-39) and reverse (59-CGATGCGGCCGCTCAAACTTCTGACCTAAT-39) primers. The PCR product was inserted into the EcoRI and NotI sites of pGEX-5X-2 (GE Healthcare) under the control of the tac promoter, and the product, fused to GST, was then expressed in E. coli BL21(DE3) (Invitrogen). E. coli was grown in Luria-Bertani medium at 37 uC until OD 600 0.5 was reached; IPTG was then added to a final concentration of 0.1 mM to induce the cells, and the bacteria were incubated at room temperature for an additional 5 h. After harvesting the bacterial culture, proteins were extracted using B-PER II Bacterial Protein Extraction Reagent (Pierce). The GST-NS1 fusion protein was purified using a glutathione-agarose (Sigma) column.
Mice immunization and mAb production. Mouse immunizations were performed according to the guidelines of the Canadian Council on Animal Care. BALB/c female mice (6-8 weeks old) were immunized with 100 ml PBS containing 40 mg HK1 66His-NS1 and equal volumes of Titre-Max Gold adjuvant (Cedarlane Laboratories). A single boost of 50 mg 66His-NS1 per mouse was given 1 month after the first immunization. The spleen cells of immunized mice were fused with myeloma SP2/0 cells at a ratio of 4 : 1 (spleen : SP 2/0). The hybridomas were grown in RPMI 1640 (Gibco, Invitrogen) with 15 % FBS and 20 % mouse spleenconditioned medium. Supernatants were screened after 13 days using 2) with HK1 wild-type or recombinant HK M124I/D125G mutant, and at 16 h p.i., the cells were lysed and differentially centrifuged to obtain whole-cell (W), nuclear (N) and cytosolic (C) fractions. The cell fractions were resuspended in SDS buffer and separated by SDS-PAGE, followed by Western blot analysis to detect the NS1 protein as well as loading markers a-tubulin and histone H3. A representative blot of two to three independent experiments is shown.
GST-NS1 of PR8 antigen by ELISA. The positive clones were screened again by ELISA and Western blotting, and were subcloned twice by the technique of limiting dilution (Harlow & Lane, 1988) .
Isotyping and purification of mAbs. Isotyping was carried out with a mouse mAb isotyping kit (Amersham). mAbs were purified on protein G columns (GE Healthcare) after the hybridomas were grown in serum-free RPMI (Gibco) until the death of all the cells (~2 weeks). The supernatants were collected, passed through protein G columns, washed five times with PBS and eluted with glycine elution buffer (pH 2.7). The glycine was removed by dialysis in PBS and the concentrations of the purified antibodies were determined using a bicinchoninic acid assay (Pierce).
Viruses and cell lines. IAV strains PR8 (H1N1), B59 (H1N1), NCal (H1N1), NY55 (H3N2), HK1 (H3N2) and B10 (H3N2) ( Table 1) were grown in 10-day-old embryonated chicken eggs. Viral stocks were titrated in MDCK cells by a standard plaque assay (Brown, 1990 Immunofluorescent microscopy. MDCK cells were infected with IAV (m.o.i. 1 and 5) and harvested at various times (0 and 6-24 h p.i.). Cells were fixed with 3-4 % paraformaldehyde for 15 min, permeabilized with 0.1 % Triton X-100 for 5 min, blocked with 1 % BSA in PBS for 1.5 h and treated with each purified mAb in 1 % BSA/ PBS overnight at 4 uC. Cells were washed four times with PBS and then treated with Alexa Fluor 546 (diluted 1 : 250; Invitrogen)-conjugated goat anti-mouse secondary antibodies in 1 % BSA/PBS for 1 h at room temperature, phalloidin 488 (diluted 1 : 200; Invitrogen) and DAPI (diluted 1 : 10 000; Invitrogen). Slides were washed three times with PBS, a drop of mounting medium was added (ProLong Gold; Invitrogen) to each spot and images were obtained with a Zeiss LSM710 laser-scanning microscope (Carl Zeiss MicroImaging), using 206 and 406 objectives.
Confocal microscopy. To observe the localization pattern of NS1 in infected cells, M1 cells were infected with recombinant HK1 wild-type, or the NS1 M124I/D125G mutant, at an m.o.i. of 3 in the absence of trypsin. At 16 h p.i., the cells were washed with PBS, fixed in 3.7 % formaldehyde for 10 min, washed with PBS and then permeabilized in 0.1 % Triton X-100 in PBS for 5 min. Following two washes in PBS, the cells were incubated with rabbit anti-HK1 NS1 polyclonal antibody or mouse anti-NS1 mAb 3F5 overnight at 4 uC. The cells were washed twice with PBS and the slides were incubated with secondary Cy3-conjugated donkey anti-rabbit or donkey antimouse IgG, respectively (Jackson ImmunoResearch Laboratories) for 2 h at room temperature. After two washes in PBS, the nuclei were stained by incubation with DAPI (300 ng ml
21
) in the dark for 15 min. Excess stain was removed by three washes with dH 2 O. Cover slides were mounted with mounting medium (Dako) following the manufacturer's protocol. The cells were viewed using a Zeiss LSM 510 META/AxioVert 200 Confocal Microscope with a 636 oil-immersion lens. Representative images were processed in parallel (GNU Image Manipulation Program 2.0).
Nuclear and cytoplasmic fractionation of infected cells. At 16 h p.i., confluent monolayers of M1 cells infected at an m.o.i. of 2 were washed once with ice-cold PBS and lysed with ice-cold NP-40 lysis buffer [50 mM Tris/HCl (pH 8.0), 150 mM NaCl, 10 % glycerol, 1 % NP-40, 1 mM EDTA], and adherent cells were collected by scraping. The cells were fractioned as described previously (Suzuki et al., 2010) . The whole cell, cytoplasmic and nuclear fractions were mixed with 46 Laemmli sample buffer and boiled for 3 min prior to protein separation by SDS-PAGE. The immunoblots were probed for NS1 (polyclonal rabbit anti-NS1), histone H3 (rabbit anti-histone H3, CT, pan, clone A35; Millipore) and a-tubulin (mouse anti-tubulin a; Sigma). Antibodies were detected by incubation with HRP-conjugated goat anti-rabbit or goat anti-mouse antibody (Sigma), followed by SuperSignal West Pico chemiluminescent substrate (Pierce, Thermo Fisher Scientific) and exposure to film.
Epitope mapping, competitive ELISA and structural placement.
Aliquots of each purified mAb were submitted to Pepscan Therapeutics (The Netherlands) for linear overlapping peptide epitope mapping (Slootstra et al., 1996) . Briefly, 216 15mer peptides were synthesized by Pepscan with 1 aa overlaps, each targeting the PR8 strain of NS1, each was bound to a Pepscan array, each array was reacted with each antibody and bound antibody was detected by ELISA with fluorescently labelled anti-mouse secondary antibody. Fluorescent intensities were recorded with a CCD camera and the intensities imported into Excel for graphing.
Competition between various epitopes was determined essentially as described by Harlow & Lane (1988) . Briefly, Nunc 96-well plates were coated with 100 ml GST-PR8-NS1 (0.25 mg ml 21 ). After overnight coating, the wells were washed three times with 0.05 % Tween 20 in PBS. The plates were blocked with 1 % BSA in PBS, washed and then treated with the various tested blocking antibodies (500 mg ml 21 ) overnight at 4 uC. The plates were washed five times with 0.05 % Tween 20 in PBS and incubated with biotinylated mAb 8C7 (10 mg ml
) for 2 h. After washing three times with 0.05 % Tween 20 in PBS, the wells were treated with a 1 : 2000 dilution of Extra Avidin E2636 for 1 h, washed five times with 0.05 % Tween 20 in PBS and developed with alkaline phosphatase/p-nitrophenyl phosphate. Asorbance was measured at 405 nm on a BioTek Synergy 4 plate reader.
The full-length NS1 protein of IAV strain H5N1 (Protein Data Bank 3F5T; Bornholdt & Prasad, 2008) , the only full-length NS1 protein currently available in the Protein Data Bank, was imported into and manipulated with the molecular graphics program PyMOL version 1.5.0.4 (Schrödinger, LLC).
